Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) was the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 37,800 shares, an increase of 28.6% from the November 30th total of 29,400 shares. Based on an average trading volume of 34,400 shares, the days-to-cover ratio is currently 1.1 days.

Alpha Tau Medical Price Performance

Shares of NASDAQ DRTSW opened at $0.25 on Friday. The business's 50 day moving average price is $0.28 and its two-hundred day moving average price is $0.46. Alpha Tau Medical has a twelve month low of $0.18 and a twelve month high of $1.06.

Hedge Funds Weigh In On Alpha Tau Medical

Institutional investors have recently bought and sold shares of the business. Robotti Robert bought a new stake in shares of Alpha Tau Medical during the first quarter worth approximately $31,000. Goldman Sachs Group Inc. bought a new stake in shares of Alpha Tau Medical in the first quarter valued at approximately $42,000. Atalaya Capital Management LP bought a new stake in shares of Alpha Tau Medical in the first quarter valued at approximately $48,000. Chicago Partners Investment Group LLC bought a new stake in shares of Alpha Tau Medical in the first quarter valued at approximately $55,000. Finally, Spring Creek Capital LLC bought a new stake in shares of Alpha Tau Medical in the first quarter valued at approximately $61,000.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers.

Read More

• Get a free copy of the StockNews.com research report on Alpha Tau Medical (DRTSW)
• MarketBeat: Week in Review 12/26 – 12/30
• The Dogs Of Tech: It's Time For A Bite Of These Stocks
• Does This Acquisition Make Microsoft a Bear Market Buy?
• Should You Warm up to Generac Stock for the Winter?
• Is Kintara Therapeutics A Hidden Gem?

Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.